Preterm Delivery and Low Birth Weight Among Neonates Conceived With Intracytoplasmic Sperm Injection Compared With Conventional In Vitro Fertilization

2018 ◽  
Vol 131 (2) ◽  
pp. 262-268 ◽  
Author(s):  
Sanaz Keyhan ◽  
Tracy Truong ◽  
Yi-Ju Li ◽  
Tia Jackson-Bey ◽  
Jennifer L. Eaton
Keyword(s):  
Birth Weight ◽  
In Vitro Fertilization ◽  
Low Birth Weight ◽  
Preterm Delivery ◽  
Intracytoplasmic Sperm Injection ◽  
Vitro Fertilization

scholarly journals Maternal Age and Its Relationship to Multiple Birth, Low Birth Weight and Preterm Delivery in In Vitro Fertilization(IVF)Pregnancies

1999 ◽  
Vol 45 (4, Part 2 of 2) ◽  
pp. 257A-257A
Author(s):  
Suzanne C Tough ◽  
Cal Greene ◽  
Larry Svenson ◽  
Ana Claro ◽  
Jaques Belik
Keyword(s):  
Birth Weight ◽  
In Vitro Fertilization ◽  
Low Birth Weight ◽  
Preterm Delivery ◽  
Maternal Age ◽  
Multiple Birth ◽  
Vitro Fertilization

Effects of in vitro fertilization on low birth weight, preterm delivery, and multiple birth

2000 ◽  
Vol 136 (5) ◽  
pp. 618-622 ◽  
Author(s):  
Suzanne C. Tough ◽  
Calvin A. Greene ◽  
Larry W. Svenson ◽  
Jaques Belik
Keyword(s):  
Birth Weight ◽  
In Vitro Fertilization ◽  
Low Birth Weight ◽  
Preterm Delivery ◽  
Multiple Birth ◽  
Vitro Fertilization

scholarly journals PRETERM BIRTH AND LOW BIRTH WEIGHT IN SINGLETON PREGNANCIES AFTER IN VITRO FERTILIZATION- INFLUENCE OF INFERTILITY AND METHOD OF FERTILIZATION

2021 ◽  
Vol 27 (4) ◽  
pp. 4010-4013
Author(s):  
Sergei Slavov ◽  
◽  
Galina Yaneva ◽  
Keyword(s):  
Birth Weight ◽  
Preterm Birth ◽  
In Vitro Fertilization ◽  
Low Birth Weight ◽  
Male Infertility ◽  
Average Weight ◽  
Tubal Infertility ◽  
Vitro Fertilization ◽  
Singleton Pregnancies

The aim of our study was to determine the effect of infertility and the method of fertilization on the frequency of preterm birth and low birth weight in singleton pregnancies achieved by in vitro fertilization (IVF). The study was conducted in the period 01.2013 - 12.2017 and included 286 patients with births from singleton IVF pregnancies. Classical IVF received 107 patients (group A1) and ICSI fertilization - 148 (group A2). Cases with tubal infertility were 81 (group B1), and 85 were with male infertility (group B2). In group A1, birth prior to 37 weeks of gestation (w.g.) was found in 33 (30.8%) cases, compared to 26 (17.6%) in group A2 (p=0.029).In group A1, birth weight <2500 g was observed in 27 (25.3%) of cases, and in group A2 - in 17 (11.5%) of cases (p=0.015). In group B1, birth prior to 37 w.g. was established in 26 (32.1%) of the cases, compared to 9 (10.6%) in group B2 (p=0.003). In group B1 there was birth weight <2500 g in 19 (23.5%) of patients, compared to 6 (7.1%) in group B2 (p = 0.009). The average weight of the newborn and average duration of pregnancy was lower in groups with IVF fertilization and tubal infertility compared to ICSI fertilization and male infertility. Tubal infertility and classical IVF fertilization are independent risk factors that increase the frequency of preterm birth and low birth weight in IVF singleton pregnancies.

scholarly journals Analysis of in vitro fertilization/intracytoplasmic sperm injection outcomes in infertile women with a history of thyroid cancer: a retrospective study

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Ning Huang ◽  
Lin Zeng ◽  
Jie Yan ◽  
Hongbin Chi ◽  
Jie Qiao
Keyword(s):  
Thyroid Cancer ◽  
In Vitro Fertilization ◽  
Preterm Delivery ◽  
Intracytoplasmic Sperm Injection ◽  
Obstetric Outcomes ◽  
Control Group ◽  
High Grade ◽  
Vitro Fertilization ◽  
History Of

Abstract Background Recent studies have revealed that women with infertility have a higher risk of thyroid cancer (TC) than fertile women. However, studies on whether a history of thyroid cancer affects clinical outcomes in women who conceive using in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) are scarce. We investigate whether a history of thyroid cancer (TC) affects the in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes and increases the risk of adverse obstetric outcomes in women with infertility. Methods This retrospective study enrolled 384 women with infertility who underwent their first IVF/ICSI treatment at the Peking University Third Hospital between 2010 and 2019. Participants were divided into the TC (64 women with TC history) and control (320 women matched from 85,272 women without thyroid diseases) groups. Controls were individually matched to the TC group according to age, body mass index, concomitant infertility factors, first IVF/ICSI dates, and controlled ovarian stimulation and embryo transfer procedure protocols. IVF/ICSI outcomes, including the numbers of retrieved oocytes and high-grade embryos, clinical pregnancy, miscarriage, preterm delivery, and live birth rates, and adverse obstetric outcome risk were assessed. Results The TC group had significantly higher thyroid hormone and lower thyroid-stimulating hormone (TSH) levels than the control group. Despite similar gonadotropin treatment dosage, the TC group had a significantly lower numbers of retrieved oocytes and high-grade embryos than the control group. The occurrence rates of clinical pregnancy, miscarriage, preterm delivery, live births, and adverse obstetric outcomes, including multiple gestation, preterm delivery, gestational diabetes mellitus, gestational hypertension, low birth weight, and large-for-gestational-age infants, were not significantly different between the two groups. Conclusions TC history did not affect the pregnancy outcomes or increase the risk of adverse obstetric outcomes after the first IVF/ICSI, but it may decrease the number of retrieved oocytes and high-grade embryos.

Sign in / Sign up

Export Citation Format

Share Document